# Advisor Review - GPT-5-mini

**Role:** Academic advisor checking for fatal errors
**Model:** openai/gpt-5-mini
**Paper:** paper.pdf
**Timestamp:** 2026-02-04T03:04:12.281996
**Route:** OpenRouter + LaTeX
**Tokens:** 19997 in / 1668 out
**Response SHA256:** 9b8e230217ff7c80

---

I reviewed the full LaTeX draft for fatal errors in the four required domains (Data-Design Alignment, Regression Sanity, Completeness, Internal Consistency), focusing only on the criteria you specified. I checked all tables, figures, sample definitions, timing statements, and regression reporting for the explicit "fatal" conditions listed in your instructions.

Findings (high-level)
- I found no fatal errors. The treatment timing (retail openings in 2014) is within the data coverage (2010–2019). Post-treatment observations exist for the treated cohorts, and the Washington/Oregon border handling (restricting WA-OR to the pre-Oregon-retail window) is explicitly documented and internally consistent. Treatment definitions and dates are consistent across the text, the border-pair table, and the sample construction description.
- All regression tables report standard errors, Ns, and clustering units. I did not find implausible or impossible numerical values (no SEs >> outcome scale, no NA/Inf, no R^2 outside [0,1], no negative standard errors). Numbers cited in text (point estimates, SEs, CIs) match the values in tables.
- No placeholder text (NA/TBD/TODO/XXX/PLACEHOLDER) or empty table cells appear in the provided LaTeX source. Required elements (N, SE, p/q-values, clustering level) are reported where relevant.
- Specification choices that could be debated (e.g., clustering with 8 clusters, BRL/wild bootstrap use) are acknowledged and alternative inference methods are reported; this is described transparently and not a fatal error under your rubric.

I list the checks I performed against your fatal criteria to be explicit:

1) Data-Design Alignment
- Treatment timing vs data coverage: Treatment retail dates = Jan 1 2014 (CO) and July 2014 (WA). Data sample 2010–2019. Max(treatment year)=2014 ≤ max(data year)=2019 — OK.
- Post-treatment observations: Post-treatment quarters exist for both CO and WA in the 2014–2019 window; WA-OR border is explicitly restricted pre-Oregon-retail and that restriction is documented in the appendix — OK.
- Treatment definition consistency: Border-pair table (retail dates) matches the treatment description in text; no contradictory "first treated year" elsewhere — OK.

2) Regression Sanity
- Standard errors / coefficients: No SEs implausibly large relative to coefficients or outcomes. Example checks:
  - Table "Main DiDisc" Column (4): coefficient -0.031, SE 0.062 — reasonable.
  - Industry table: largest coefficient magnitude -0.130 with SE 0.030 — plausible (not >100, SE not >100×coef).
  - R² values reported in main table are within [0,1].
- No negative standard errors, no "NA"/"Inf", no R² outside [0,1] present in tables — OK.

3) Completeness
- No placeholder markers (NA/TBD/TODO/PLACEHOLDER) in tables or text.
- Regression tables report N (observations, counties, clusters) and standard errors; industry table reports N per industry.
- Figures and tables referenced in text exist in the appendix and are labeled; placebo tests and robustness checks are reported rather than only described — OK.

4) Internal Consistency
- Numbers cited in the abstract and main text (point estimates, SEs, CIs) match the values in the tables.
- Sample period and treatment timing are used consistently across sections (pre/post windows for CO and WA are described consistently).
- Column headers and specification descriptions align with reported controls and fixed effects (e.g., Column (4) labeled "Full DiDisc" corresponds to border-pair-by-quarter FE as stated).

Conclusion
I did not identify any fatal errors under the four-category checklist you provided.

ADVISOR VERDICT: PASS